Capreomycin kinetics in renal impairment and clearance by hemodialysis.

The single-dose kinetics of capreomycin are described for 12 renal patients and seven healthy control subjects. Creatinine clearances (CrCl) ranged from zero to 121 ml/min. After single-dose intravenous infusions, mean +/- SD capreomycin clearance values (L/kg/h x 10(-2)) were 0.558 +/- 0.160 for the dialysis group (n = 4, CrCl = 1.4 +/- 1.9), 1.77 +/- 0.45 for the moderate renal group (n = 3, CrCl = 25 +/- 5), 2.82 +/- 1.52 for the mild renal group (n = 4, CrCl = 46 +/- 5), and 5.73 +/- 1.54 for the normal renal group (n = 7, CrCl = 109 +/- 11); p less than 0.01, using analysis of variance. The correlation between capreomycin clearance and CrCl was r = 0.90. Hemodialysis cleared clinically significant amounts of capreomycin. These data imply that capreomycin maintenance doses need to be reduced for renal patients.

[1]  T. J. O'Neil,et al.  Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis , 1985, Clinical pharmacology and therapeutics.

[2]  J. Hawkins,et al.  M. TUBERCULOSIS IN VITRO SUSCEPTIBILITY AND SERUM LEVEL EXPERIENCES WITH CAPREOMYCIN , 1966, Annals of the New York Academy of Sciences.

[3]  R. Griffith,et al.  ABSORPTION, EXCRETION AND METABOLISM OF CAPREOMYCIN IN NORMAL AND DISEASED STATES , 1966, Annals of the New York Academy of Sciences.

[4]  I. Donomae.  CAPREOMYCIN IN THE TREATMENT OF PULMONARY TUBERCULOSIS , 1966, Annals of the New York Academy of Sciences.

[5]  John D. Miller,et al.  TOXICOLOGY STUDIES IN PATIENTS ON PROLONGED THERAPY WITH CAPREOMYCIN , 1966, Annals of the New York Academy of Sciences.

[6]  N. Cohen,et al.  THE AUDITORY, VESTIBULAR AND RENAL EFFECTS OF CAPREOMYCIN IN HUMANS , 1966, Annals of the New York Academy of Sciences.